Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-004377

Options or other derivatives

  • Chief Operating Officer acquired 1,924,128 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bertrand William C JR Chief Operating Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +1,407,072 1,407,072 D
Bertrand William C JR Chief Operating Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +314,256 314,256 D
Bertrand William C JR Chief Operating Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +202,800 202,800 D
Loading xslF345X03/tm231655-16_4seq1.xml…